| scholarly article | Q13442814 |
| P356 | DOI | 10.7326/0003-4819-98-5-585 |
| P698 | PubMed publication ID | 6846971 |
| P50 | author | Edward Stinson | Q55610560 |
| P2093 | author name string | M L Weisfeldt | |
| R A Winkle | |||
| M Mirowski | |||
| M M Mower | |||
| L S Griffith | |||
| P R Reid | |||
| L Watkins | |||
| C H Kallman | |||
| P433 | issue | 5 Pt 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 585-588 | |
| P577 | publication date | 1983-05-01 | |
| P1433 | published in | Annals of Internal Medicine | Q564416 |
| P1476 | title | Mortality in patients with implanted automatic defibrillators | |
| P478 | volume | 98 |
| Q34100496 | A Canadian hospital's experience with the automatic implantable cardioverter/defibrillator |
| Q70684408 | Advances in the management of cardiac arrhythmias in children |
| Q41421328 | Automatic external defibrillation: evaluations of its role in the home and in emergency medical services |
| Q42086645 | Automatic external defibrillators: clinical, training, psychological, and public health issues |
| Q33744454 | Automatic external defibrillators: lessons from the past, present and future. |
| Q68190780 | Automatic implantable cardioverter-defibrillator implantation without thoracotomy using an endocardial and submuscular patch system |
| Q69026943 | Automatic implantable cardioverter-defibrillator: patient survival, battery longevity and shock delivery analysis |
| Q40926596 | Can implantable cardioverter-defibrillator therapy reduce healthcare costs? |
| Q41757504 | Cardiopulmonary resuscitation: a review for clinicians |
| Q56271168 | Causes of death in the antiarrhythmics versus implantable defibrillators (AVID) trial |
| Q67730518 | Comment on the implantable defibrillator backlash |
| Q35566077 | Community-based responses to impending or actual cardiac arrest and advances in post-cardiac arrest care |
| Q67705225 | Comparative Efficacy of Subcutaneous Mesh and Plate Electrodes for Nonthoracotomy Canine Defibrillation |
| Q40601626 | Cost-effectiveness analysis in heart disease, Part III: Ischemia, congestive heart failure, and arrhythmias |
| Q39828480 | Current status of surgery for ventricular tachyarrhythmias |
| Q44559442 | Defibrillation with Low Voltage using a Left Ventricular Catheter and Four Cutaneous Patch Electrodes in Dogs |
| Q34821621 | Devices for the management of ventricular arrhythmias in cardiac failure |
| Q71111966 | Drug therapy versus implantation of a cardiac defibrillator for the treatment of malignant arrhythmias in left ventricular dysfunction |
| Q41120695 | Drugs or implantable cardioverter-defibrillators in patients with poor left ventricular function? |
| Q68282907 | Effect of electrophysiological testing on ejection fraction during cardioverter/defibrillator implantation |
| Q54373882 | Effects of simulated intraoperative electrophysiological testing on function of the canine left ventricle. |
| Q41312581 | Efficacy of an implanted automatic defibrillator which had induced atrial fibrillation |
| Q69593738 | Electrical catheter ablation in the left and right ventricular wall in dogs: relation between delivered energy and histopathologic changes |
| Q41414574 | Electronic Control of Ventricular Tachyarrhythmias: Overview and Future Directions |
| Q72751587 | Epicardial Implantation of the Automatic Implantable Defibrillator by Left Subcostal Tboracotomy |
| Q33789879 | Evaluating AVID, CASH, CIDS, CABG-patch and MADIT: are they concordant? |
| Q34085397 | Evidence rather than costs must guide use of the implantable cardioverter defibrillator |
| Q33612111 | Experience of cardioverter-defibrillators inserted without thoracotomy: evaluation of transvenously inserted intracardiac leads alone or with a subcutaneous axillary patch |
| Q36662487 | Future Studies with the Implantable Cardioverter Defibrillator |
| Q43834813 | Guidelines for implantation of cardiac pacemakers and antiarrhythmia devices. A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Committee on Pa |
| Q40926626 | Impact of implant techniques on complications with current implantable cardioverter-defibrillator systems |
| Q72751571 | Implantable Cardioverter-Defibrillator: Patient Selection and Implantation Protocol |
| Q44692922 | Implantable cardioverter defibrillator events in patients with asymptomatic nonsustained ventricular tachycardia: is device implantation justified? |
| Q70880364 | Implantable cardioverter defibrillator: use in patients with no symptoms and at high risk |
| Q77739489 | Implantable cardioverter-defibrillator therapy: influence of left ventricular function on long-term results |
| Q38756165 | Implantable cardioverters and defibrillators |
| Q67698807 | Inability of the Signal-Averaged Electrocardiogram to Determine Risk of Arrhythmia Recurrence in Patients with Implantable Cardioverter Defibrillators |
| Q70032017 | Inducibility and reproducibility of ventricular arrhythmias: therapeutic implications |
| Q41276546 | Lessons learned from the automatic implantable cardioverter-defibrillator: Past, present and future |
| Q44517867 | Long-Term Community Hospital Experience with the Internal Defibrillator |
| Q69495372 | Management of arrhythmias in heart failure |
| Q43243086 | Managing ventricular tachyarrhythmias in the developing world: insights from recent ICD trials. |
| Q34085399 | Matching cardiac rhythm management technology to patient needs: pacing/ablation/implantable cardioverter defibrillators |
| Q69562789 | Medical, legal, and social implications of automatic external defibrillators |
| Q45957265 | Mortality benefit of implantable cardioverter-defibrillator therapy in patients with persistent malignant ventricular arrhythmias despite amiodarone treatment. |
| Q40991169 | Nonpharmacological therapy for malignant ventricular arrhythmias: implantable defibrillator trials |
| Q69062291 | Nonthoracotomy internal defibrillation in dogs: threshold reduction using a subcutaneous chest wall electrode with a transvenous catheter electrode |
| Q67685476 | Occurrence of ICD Shocks and Patient Survival |
| Q69062288 | Pathologic findings related to the lead system and repeated defibrillations in patients with the automatic implantable cardioverter-defibrillator |
| Q40485755 | Patient Survival Comparison in Three Generations of Automatic Implantable Cardioverter Defibrillators: Review of 12 Years, 25,000 Patients |
| Q72737236 | Potential Hazards of Implanted Devices for the Electrical Control of Tachyarrhythmias |
| Q44354297 | Prevention of sudden death in survivors of myocardial infarction: A decision analysis approach |
| Q50980667 | Previous open heart operation: a contribution to impaired outcome after cardiac transplantation? |
| Q33581347 | Recent trends in the management of life-threatening ventricular arrhythmias |
| Q68498042 | Relation of the intraoperative defibrillation threshold to successful postoperative defibrillation with an automatic implantable cardioverter defibrillator |
| Q74630662 | Safety and efficacy of implantable defibrillator therapy with programmed shock energy at twice the augmented step-down defibrillation threshold: results of the prospective, randomized, multicenter Low-Energy Endotak Trial |
| Q72584946 | Sensitivity, accuracy, and safety of an automatic external defibrillator |
| Q45170638 | Sudden cardiac death unresponsive to implantable defibrillator therapy: an urgent target for clinicians, industry and government |
| Q77947832 | Sudden death in patients with implantable cardioverter defibrillators: the importance of post-shock electromechanical dissociation |
| Q38573707 | The Antitachycardia Pacing ICD: Impact on Patient Selection and Outcome |
| Q72737227 | The Automatic Implantable Cardioverter-Defibrillator |
| Q40485884 | The Effect of the Implantable Cardioverter Defibrillator on Sudden Death and on Total Survival |
| Q67694041 | The Surgical Aspects of Automatic Implantable Cardioverter-Defibrillator Implantation |
| Q44656449 | The automatic implantable cardioverter defibrillator: Efficacy, complications and survival in patients with malignant ventricular arrhythmias |
| Q39825095 | The automatic implantable cardioverter-defibrillator: an overview |
| Q70032063 | The automatic implantable cardioverter-defibrillator: evaluating suspected inappropriate shocks |
| Q69607633 | The automatic internal cardioverter defibrillator (AICD): description and guidelines for interaction during cardiac arrest |
| Q33145454 | The implantable cardioverter-defibrillator. |
| Q38837782 | The implantable defibrillator and the emergency physician |
| Q93649174 | The implanted defibrillator: relation of defibrillating lead configuration and clinical variables to defibrillation threshold |
| Q73744527 | There should never be another antiarrhythmics versus implantable defibrillator (AVID) trial |
| Q70663642 | Timing of the right ventricular apical electrogram during sustained ventricular tachycardia: relation to surface QRS morphology and potential clinical implications |
| Q71835698 | Transvenous Cardioverter Defibrillators: Cost Implications of a Less Invasive Approach |
| Q69584800 | Treatment of malignant ventricular arrhythmias with the automatic implantable cardioverter defibrillator |
| Q40075874 | Ventricular Premature Beats, Ventricular Tachycardia, and Sudden Cardiac Death: Identification of Patients and Drug Treatment |
| Q52897657 | Why the antiarrhythmics versus implantable defibrillator (AVID) trial sets the wrong precedent. |
| Q83995824 | [Influence of waveform and configuration of electrodes on the defibrillation threshold of implantable cardioverter-defibrillators] |
| Q73998813 | [The current status of implantable automatic defibrillators] |
Search more.